Skip to main content

Table 1 Characteristics of DMBA-induced tumours from control and Mmtv-Ccl2 mice

From: CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model

Genotype

Latency (weeks)

Histopathology

Mitotic index

Inflammation

Control

13

Spindeloid carcinoma

0

2

 

10

Adenosqaumous carcinoma

3

5

 

14

Adenosqaumous carcinoma

2

2

 

16

Early MIN

0

0

 

10

Adenosquamous carcinoma

N/A

4

 

12

Adenosquamous carcinoma

1

4

 

11

Carcinosarcoma

0

2

 

10

Early MIN

0

1

Mmtv-Ccl2

10

Acinar

0

0

 

11

Adenosquamous carcinoma

N/A

2

 

10

Adenosquamous carcinoma

2

5

 

19

Early MIN

0

0

 

10

Adenosqaumous carcinoma

0

2

 

13

Glandular carcinoma

0

2

 

13

Cribiform carcinoma

1

4

 

8

Adenosquamous carcinoma

1

5

 

19

Early MIN

0

0

  1. Latency in weeks after final 7,12-Dimethylbenz(a)anthracene (DMBA) administration. Mitotic index was determined by counting the number of mitotic cells in a × 10 field of view. Inflammation was scored as 0 (none), 1 (mild, focal), 2 (mild, multifocal), 3 (moderate, focal), 4 (moderate, multifocal) or 5 (marked, diffuse or multifocal). MIN mammary intraepithelial neoplasia, N/A not assessed